Annual Current Assets
$118.15 M
-$67.03 M-36.20%
December 31, 2023
Summary
- As of February 8, 2025, AKBA annual total current assets is $118.15 million, with the most recent change of -$67.03 million (-36.20%) on December 31, 2023.
- During the last 3 years, AKBA annual current assets has fallen by -$253.29 million (-68.19%).
- AKBA annual current assets is now -74.77% below its all-time high of $468.27 million, reached on December 31, 2018.
Performance
AKBA Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$100.12 M
-$11.98 M-10.68%
September 30, 2024
Summary
- As of February 8, 2025, AKBA quarterly total current assets is $100.12 million, with the most recent change of -$11.98 million (-10.68%) on September 30, 2024.
- Over the past year, AKBA quarterly current assets has dropped by -$11.98 million (-10.68%).
- AKBA quarterly current assets is now -78.62% below its all-time high of $468.27 million, reached on December 31, 2018.
Performance
AKBA Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
AKBA Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -36.2% | -10.7% |
3 y3 years | -68.2% | -63.1% |
5 y5 years | -74.8% | -63.1% |
AKBA Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -56.4% | at low | -67.1% | at low |
5 y | 5-year | -68.2% | at low | -77.7% | at low |
alltime | all time | -74.8% | +5165.3% | -78.6% | +199.5% |
Akebia Therapeutics Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $100.12 M(-10.7%) |
Jun 2024 | - | $112.10 M(-0.7%) |
Mar 2024 | - | $112.94 M(-4.4%) |
Dec 2023 | $123.55 M(-27.7%) | $118.15 M(+7.8%) |
Sep 2023 | - | $109.60 M(-7.5%) |
Jun 2023 | - | $118.45 M(-1.9%) |
Mar 2023 | - | $120.72 M(-34.8%) |
Dec 2022 | $170.87 M(-33.8%) | $185.18 M(-22.0%) |
Sep 2022 | - | $237.51 M(-21.9%) |
Jun 2022 | - | $304.16 M(+0.5%) |
Mar 2022 | - | $302.69 M(+11.6%) |
Dec 2021 | $258.20 M(-5.3%) | $271.15 M(-17.9%) |
Sep 2021 | - | $330.08 M(-0.3%) |
Jun 2021 | - | $331.08 M(-9.3%) |
Mar 2021 | - | $365.02 M(-1.7%) |
Dec 2020 | $272.70 M(-40.9%) | $371.44 M(-5.0%) |
Sep 2020 | - | $391.00 M(-12.9%) |
Jun 2020 | - | $449.10 M(+31.8%) |
Mar 2020 | - | $340.76 M(+10.1%) |
Dec 2019 | $461.67 M | $309.53 M(+3.5%) |
Sep 2019 | - | $299.01 M(-5.5%) |
Jun 2019 | - | $316.40 M(-8.9%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $347.23 M(-25.8%) |
Dec 2018 | $528.26 M(+8867.3%) | $468.27 M(+17.8%) |
Sep 2018 | - | $397.53 M(-2.4%) |
Jun 2018 | - | $407.42 M(-6.8%) |
Mar 2018 | - | $436.98 M(+21.9%) |
Dec 2017 | $5.89 M(+51.2%) | $358.36 M(+7.3%) |
Sep 2017 | - | $333.94 M(+0.5%) |
Jun 2017 | - | $332.39 M(+30.3%) |
Mar 2017 | - | $255.05 M(-13.9%) |
Dec 2016 | $3.90 M(+102.5%) | $296.32 M(+79.4%) |
Sep 2016 | - | $165.15 M(-14.2%) |
Jun 2016 | - | $192.52 M(-12.3%) |
Mar 2016 | - | $219.53 M(+55.7%) |
Dec 2015 | $1.92 M(+273.4%) | $141.02 M(-11.2%) |
Sep 2015 | - | $158.80 M(+2.5%) |
Jun 2015 | - | $154.96 M(+50.9%) |
Mar 2015 | - | $102.69 M(-7.0%) |
Dec 2014 | $515.00 K(-58.3%) | $110.48 M(-7.8%) |
Sep 2014 | - | $119.84 M(-4.9%) |
Jun 2014 | - | $126.05 M(-5.7%) |
Mar 2014 | - | $133.74 M(+300.0%) |
Dec 2013 | $1.23 M(>+9900.0%) | $33.43 M |
Dec 2012 | $0.00 | - |
FAQ
- What is Akebia Therapeutics annual total current assets?
- What is the all time high annual current assets for Akebia Therapeutics?
- What is Akebia Therapeutics annual current assets year-on-year change?
- What is Akebia Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly current assets year-on-year change?
What is Akebia Therapeutics annual total current assets?
The current annual current assets of AKBA is $118.15 M
What is the all time high annual current assets for Akebia Therapeutics?
Akebia Therapeutics all-time high annual total current assets is $468.27 M
What is Akebia Therapeutics annual current assets year-on-year change?
Over the past year, AKBA annual total current assets has changed by -$67.03 M (-36.20%)
What is Akebia Therapeutics quarterly total current assets?
The current quarterly current assets of AKBA is $100.12 M
What is the all time high quarterly current assets for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly total current assets is $468.27 M
What is Akebia Therapeutics quarterly current assets year-on-year change?
Over the past year, AKBA quarterly total current assets has changed by -$11.98 M (-10.68%)